Cargando…

Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats

Cilnidipine is an L/N-type calcium channel blocker (CCB). The effects of cilnidipine on N-type channels give it unique organ-protective properties via the suppression of hyperactivity in the sympathetic nervous system (SNS) and renin-angiotensin-aldosterone system (RAAS). In the present study, we co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aritomi, Shizuka, Harada, Eri, Sugino, Kazumi, Nishimura, Mai, Nakamura, Tarou, Takahara, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409849/ https://www.ncbi.nlm.nih.gov/pubmed/25582553 http://dx.doi.org/10.1111/1440-1681.12360

Ejemplares similares

Additive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus
por: Mori, Yutaka, et al.
Publicado: (2014)

Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats
por: Takai, Shinji, et al.
Publicado: (2013)

Inhibition of Contractility of Isolated Caprine Detrusor by the Calcium Channel Blocker Cilnidipine and Reversal by Calcium Channel Openers
por: Maria, Steffi A., et al.
Publicado: (2023)

Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
por: Gopinath, Sameera, et al.
Publicado: (2019)

Preparation and evaluation of cilnidipine microemulsion
por: Tandel, Hemal, et al.
Publicado: (2012)

Cilnidipine induced ankle edema
por: Annil, Vishal R., et al.
Publicado: (2014)

Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials
por: Chakraborty, Rabindra Nath, et al.
Publicado: (2021)

Renal Function in Hypertensive Patients Receiving Cilnidipine and L-Type Calcium Channel Blockers: A Meta-Analysis of Randomized Controlled and Retrospective Studies
por: Srivathsan, Mayakalyani, et al.
Publicado: (2022)

Renoprotective Effect of Plantago major Against Proteinuria and Apoptosis Induced by Adriamycin in Rat
por: Yazd, Zohreh Naji Ebrahimi, et al.
Publicado: (2019)

Blood Pressure Reducing Potential and Renoprotective Action of Cilnidipine Among Hypertensive Patients Suffering From Chronic Kidney Disease: A Meta-Analysis
por: Kumari, Kusum, et al.
Publicado: (2023)

L/N-Type Calcium Channel Blocker Cilnidipine Added to Renin-Angiotensin Inhibition Improves Ambulatory Blood Pressure Profile and Suppresses Cardiac Hypertrophy in Hypertension with Chronic Kidney Disease
por: Kanaoka, Tomohiko, et al.
Publicado: (2013)

Effects of Cilnidipine, an L/N-Type Calcium Channel Blocker, on Carotid Atherosclerosis in Japanese Post-Stroke Hypertensive Patients: Results from the CA-ATTEND Study
por: Nezu, Tomohisa, et al.
Publicado: (2018)

Effects of the N/L‐Type Calcium Channel Blocker Cilnidipine on Nephropathy and Uric Acid Metabolism in Hypertensive Patients With Chronic Kidney Disease (J‐CIRCLE Study)
por: Uchida, Shunya, et al.
Publicado: (2014)

Excellent Tolerance to Cilnidipine in Hypertensives with Amlodipine - Induced Edema
por: Shetty, Ranjan, et al.
Publicado: (2013)

Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease
por: Huang, Rong-Shuang, et al.
Publicado: (2016)

Serum Triglyceride Lowering Effect of Cilnidipine in Patients With Essential Hypertension
por: Kumar, Prakash, et al.
Publicado: (2016)

Renoprotective and Cardioprotective Potential of Moricandia sinaica (Boiss.) against Carbon Tetrachloride-Induced Toxicity in Rats
por: Shahat, Abdelaaty A., et al.
Publicado: (2022)

Renoprotective Effects of a Highly Selective A3 Adenosine Receptor Antagonist in a Mouse Model of Adriamycin-induced Nephropathy
por: Min, Hye Sook, et al.
Publicado: (2016)

Are Calcium Antagonists Cardioprotective?
por: Kendall, M. J., et al.
Publicado: (1985)

Renoprotective effects of renin–angiotensin system inhibitor combined with calcium channel blocker or diuretic in hypertensive patients: A PRISMA-compliant meta-analysis
por: Cheng, Yiming, et al.
Publicado: (2016)

Cardioprotective Mechanism and Active Compounds of Folium Ginkgo on Adriamycin-Induced Cardiotoxicity: A Network Pharmacology Study
por: Sun, Xue, et al.
Publicado: (2022)

Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers
por: Lee, Jieon, et al.
Publicado: (2014)

Effects of Cilnidipine on Heart Rate and Uric Acid Metabolism in Patients With Essential Hypertension
por: Das, Arijit, et al.
Publicado: (2016)

Comparative effects of valsartan plus cilnidipine or hydrochlorothiazide on nocturnal home blood pressure
por: Fujiwara, Takeshi, et al.
Publicado: (2021)

Single‐pill combination of cilnidipine, an l‐/n‐type calcium channel blocker, and valsartan reduces the day‐by‐day variability of morning home systolic blood pressure in patients with treated hypertension: A sub‐analysis of the HOPE‐combi survey
por: Kario, Kazuomi, et al.
Publicado: (2021)

Reduction of microalbuminuria in type-2 diabetes mellitus with angiotensin-converting enzyme inhibitor alone and with cilnidipine
por: Singh, V. K., et al.
Publicado: (2015)

Possible renoprotective mechanisms of SGLT2 inhibitors
por: Nishiyama, Akira, et al.
Publicado: (2023)

Pre-Clinical Investigation of Cardioprotective Beta-Blockers as a Therapeutic Strategy for Preeclampsia
por: Binder, Natalie K., et al.
Publicado: (2021)

Renoprotective Effect of the Mineralocorticoid Receptor Antagonist Esaxerenone
por: Oshima, Akira, et al.
Publicado: (2021)

Cardioprotective Effects of a Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, in Dahl Salt-Sensitive Hypertensive Rats
por: Rahman, Asadur, et al.
Publicado: (2021)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Renoprotection Provided by Dipeptidyl Peptidase-4 Inhibitors in Combination with Angiotensin Receptor Blockers in Patients with Type 2 Diabetic Nephropathy
por: Qiu, Dan-Dan, et al.
Publicado: (2018)

Calcium channel blocker in patients with chronic kidney disease
por: Ohno, Shoko, et al.
Publicado: (2021)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Renoprotective effects of garlic
por: Nasri, Hamid
Publicado: (2013)

Renoprotective effects of metformin
por: Nasri, Running Hamid
Publicado: (2013)

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

Cilnidipine lowered psychological stress-induced increase in blood pressure in a hypertensive man: a case report
por: Hayashida, Sota, et al.
Publicado: (2007)

Cilnidipine and magnesium sulfate supplement ameliorates hyperglycemia, dyslipidemia and inhibits oxidative-stress in fructose-induced diabetic rats
por: Khatun Kali, Most. Sumaiya, et al.
Publicado: (2021)

Renoprotective Action of a Matrix Metalloproteinase Inhibitor in Progressive Mesangioproliferative Nephritis
por: Kuroda, Takayuki, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jurp6l9iag9c162ji07vsi2d18